These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11451213)

  • 1. Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil.
    von Bergmann K; Laeis P; Püchler K; Sudhop T; Schwocho LR; Gonzalez L
    J Hypertens Suppl; 2001 Jun; 19(1):S33-40. PubMed ID: 11451213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction.
    Laeis P; Püchler K; Kirch W
    J Hypertens Suppl; 2001 Jun; 19(1):S21-32. PubMed ID: 11451211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension.
    Wells TG; Blowey DL; Sullivan JE; Blumer J; Sherbotie JR; Song S; Rohatagi S; Heyrman R; Salazar DE
    Paediatr Drugs; 2012 Dec; 14(6):401-9. PubMed ID: 22880942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension.
    Kodati D; Kotakonda HK; Yellu N
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):573-581. PubMed ID: 27535556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of olmesartan medoxomil.
    Brunner HR; Laeis P
    J Hypertens Suppl; 2003 May; 21(2):S43-6. PubMed ID: 12929907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects.
    Kreutz R; Bolbrinker J; Huber M
    Clin Drug Investig; 2006; 26(1):29-34. PubMed ID: 17163232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients.
    Yoshihara K; Gao Y; Shiga H; Wada DR; Hisaoka M
    Clin Pharmacokinet; 2005; 44(12):1329-42. PubMed ID: 16372830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers.
    Huber M; Bolbrinker J; Kreutz R
    Clin Exp Hypertens; 2006 Oct; 28(7):631-43. PubMed ID: 17060062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview.
    Brunner HR
    J Hum Hypertens; 2002 May; 16 Suppl 2():S13-6. PubMed ID: 11967728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations.
    Jiang J; Liu D; Hu P
    Pharmazie; 2009 May; 64(5):323-6. PubMed ID: 19530443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmesartan medoxomil: an angiotensin II-receptor blocker.
    Brousil JA; Burke JM
    Clin Ther; 2003 Apr; 25(4):1041-55. PubMed ID: 12809956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics.
    Tanaka H; Nagasawa Y; Matsui I; Hamano T; Iwatani H; Kawada N; Horio M; Ito T; Isaka Y; Imai E
    Clin Exp Nephrol; 2009 Feb; 13(1):61-5. PubMed ID: 18574553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects.
    Chae JW; Baek IH; Seo JW; Jung SH; Back HM; Song BJ; Lee BY; Yun HY; Kang W; Kwon KI
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):676-83. PubMed ID: 24849193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.
    Martin DE; Chapelsky MC; Ilson B; Tenero D; Boike SC; Zariffa N; Jorkasky DK
    J Clin Pharmacol; 1998 Feb; 38(2):129-37. PubMed ID: 9549643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
    Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysis.
    Tanigawara Y; Yoshihara K; Kuramoto K; Arakawa K
    Drug Metab Pharmacokinet; 2009; 24(4):376-88. PubMed ID: 19745564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan medoxomil.
    Warner GT; Jarvis B
    Drugs; 2002; 62(9):1345-53; discussion 1354-6. PubMed ID: 12076183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.